Immunocytokines for cancer treatment in combination with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61K 31/337 (2006.01) A61K 31/704 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2692263

This invention relates to the treatment of cancer using anti-cancer agents, such as doxorubicin or paclitaxel, in combination with antibody- interleukin 2(IL2) conjugates which target tenascin- C.

Cette invention porte sur le traitement du cancer à l'aide d'agents anti-cancer, tels que la doxorubicine ou le paclitaxel, en combinaison avec des conjugués anticorps-interleukine 2 (IL2) qui ciblent la ténascine-C.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunocytokines for cancer treatment in combination with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunocytokines for cancer treatment in combination with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunocytokines for cancer treatment in combination with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1534421

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.